Skip to main content

Icosapent Ethyl

Generic: icosapent ethyl

Verified·Apr 23, 2026
Manufacturer
Amarin
NDC
35916-1592
RxCUI
1304979
Route
ORAL
ICD-10 indication
E78.1

Affordability Check

How much will you actually pay for Icosapent Ethyl?

In 30 seconds, see every legitimate way to afford Icosapent Ethyl — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Icosapent Ethyl

What is this medication?

Icosapent ethyl is a prescription medication that consists of a highly purified form of the omega-3 fatty acid known as eicosapentaenoic acid, or EPA. It is primarily used to lower very high levels of triglycerides in adults, which are a type of fat found in the blood. When triglyceride levels are 500 mg/dL or higher, they can increase the risk of developing pancreatitis. This medication is typically used in conjunction with a low-fat and low-cholesterol diet to help patients manage these lipid levels effectively.

Beyond lowering triglycerides, icosapent ethyl is also approved to reduce the risk of heart attack, stroke, and certain types of heart surgery in specific high-risk patients. This includes adults who have established cardiovascular disease or those with diabetes and multiple other risk factors for heart disease. It is meant to be taken alongside a statin, which is another type of cholesterol-lowering drug. Unlike many common fish oil supplements, this medication is a purified form of EPA and does not include DHA, ensuring it does not raise low-density lipoprotein cholesterol levels.

Copay & patient assistance

  • Patient Copay Amount: As little as $9 for a 90-day supply (approximately $3 per month); patient pays the first $9 of the prescription cost.
  • Maximum Annual Benefit Limit: $2,250 per calendar year (maximum savings of $150 per 1-month fill or $450 per 3-month fill).
  • Core Eligibility Restrictions: Offer is valid for adult patients with a valid prescription; must have commercial insurance or be a cash-paying uninsured patient; patients enrolled in Medicare, Medicaid, TRICARE, or any other federal or state-funded healthcare program are ineligible; offer is void in California (CA) and Massachusetts (MA).
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Icosapent Ethyl appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

34%

1,888 of 5,509 plans

Most common tier

Tier 4

On 32% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)53
26%
Tier 2 (generic)57
28%
Tier 3 (preferred brand)31
15%
Tier 4 (non-preferred brand)66
32%

Step therapy: 0% of formularies

Quantity limits: 57% of formularies

Coverage breadth: 207 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.